Beryl Drugs share news, announcements and annual reports
BSE: 524606Pharmaceuticals & BiotechnologySmall Cap
Beryl Drugs Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1994
Last close ₹23.60down ₹2.00 (7.81%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹25.60.
2 Nov: open ₹23.16, high ₹25.30, low ₹23.16
52-week range of traded prices to 2 Nov 2026
₹15.92Low, 4 Mar 2026₹27.90High, 21 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹12 Cr4,587th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.17
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.21
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.24
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,545
Beryl Drugs board meetings
153 filed, newest first. Page 2 of 4.
Aug 2023
25 Aug · Board meeting
18 Aug · Board meeting
Meeting on 25 Aug 2023: annual general meeting3 Aug · Board meeting
Meeting on 12 Aug 2023: quarterly results
May 2023
30 May · Board meeting
18 May · Board meeting
Meeting on 29 May 2023: audited results
Feb 2023
13 Feb · Board meeting
3 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results
Nov 2022
14 Nov · Board meeting
4 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Sep 2022
Aug 2022
26 Aug · Board meeting
Meeting on 2 Sep 2022: annual general meeting9 Aug · Board meeting
1 Aug · Board meeting
Meeting on 9 Aug 2022: quarterly results
Jul 2022
May 2022
30 May · Board meeting
16 May · Board meeting
Meeting on 30 May 2022: audited results
Feb 2022
11 Feb · Board meeting
3 Feb · Board meeting
Meeting on 11 Feb 2022: quarterly results
Nov 2021
12 Nov · Board meeting
3 Nov · Board meeting
Meeting on 12 Nov 2021: quarterly results
Sep 2021
Aug 2021
25 Aug · Board meeting
Meeting on 3 Sep 2021: annual general meeting5 Aug · Board meeting
Meeting on 11 Aug 2021: quarterly results
Jun 2021
30 Jun · Board meeting
22 Jun · Board meeting
Meeting on 30 Jun 2021: audited results
Feb 2021
4 Feb · Board meeting
Meeting on 12 Feb 2021: quarterly results
Nov 2020
20 Nov · Board meeting
Meeting on 20 Nov 202011 Nov · Board meeting
11 Nov · Board meeting
5 Nov · Board meeting
Meeting on 11 Nov 2020: quarterly results and annual general meeting
Aug 2020
27 Aug · Board meeting
Meeting on 3 Sep 2020: quarterly results
Jul 2020
27 Jul · Board meeting
Meeting on 30 Jul 2020: audited results
Feb 2020
5 Feb · Board meeting
Meeting on 12 Feb 2020: quarterly results